253840.KQ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 09:30):

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally...

Stats
Dzisiejszy wolumen	34 586.00
Średni wolumen	578 926
Kapitalizacja rynkowa	91.63B
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW11.40 (0.20%)

Wolumen Korelacja

Długi: 0.20 (neutral)

Krótki: 0.66 (moderate)

Signal:(54.453) Neutral

Sugentech Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sugentech Inc. Korelacja - Waluta/Towar

-0.76
( moderate negative )

-0.46
( neutral )

-0.57
( weak negative )

-0.49
( neutral )

-0.47
( neutral )

0.74
( moderate )

Sugentech Inc. Finanse

Annual	2023
Przychody:	KRW7.13B
Zysk brutto:	KRW-5.88B (-82.45 %)
EPS:	KRW-1 090.03

FY	2023
Przychody:	KRW7.13B
Zysk brutto:	KRW-5.88B (-82.45 %)
EPS:	KRW-1 090.03

FY	2022
Przychody:	KRW101.40B
Zysk brutto:	KRW42.66B (42.07 %)
EPS:	KRW1 685.89

Financial Reports:

No articles found.

Sugentech Inc.

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers Multiplex BLOT disease diagnostic devices, such as immunoblot processor, semi and full automation, and molecular diagnostic systems, as well as test items; and self-testing products, including digital ovulation, pregnancy test, and early sign pregnancy test, as well as mobile testing products. It also provides point of care testing analyzers and test items for testing of M.tuberculosis, M.bovis, SARS-CoV-2 antibodies and antigens, flu A/B antigens, and CRP/hsCRP /dualCRP, as well as for measuring procalcitonin, troponin I, hemoglobinA1c, human chorionic gonadotropin, immunoglobulin E, and influenza A/B. The company was formerly known as Accugen Healthcare, Inc. and changed its name to Sugentech Inc. in October 2013. Sugentech Inc. was founded in 2011 and is headquartered in Daejeon, South Korea.